The approved doses in China are 4 mg and 6 mg for weight management, with a 9 mg dose under review for moderate-to-severe obesity
No tingles
GLP-1 Vision Side Effects: The GLP-1 vision loss lawsuit filings specifically target products including Ozempic, Wegovy, Mounjaro, and Zepbound, alleging that patients developed serious ocular conditions such as NAION without sufficient prior disclosure of these potential adverse effects
NAC without glycine is similar
The article shares perspectives on how advancing disease-modifying therapies in type 1 diabetes, the role of C-peptide as a biomarker of beta-cell function, and the preservation of endogenous insulin production could be central to long-term outcomes
In addition, as new agents enter the market, payer coverage and prior-authorization landscapes will shiftespecially with expanded medication benefits